Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Address

Lilly Corporate Center

Website

https://www.lilly.com

Classification

Sector

Healthcare

Industry Group

Drug Manufacturers

Industry

Drug Manufacturers - General

Key Executives

Ms. Gabrielle Sulzberger

Director

Mr. Jon Erik Fyrwald

Director

Mr. Juan R. Luciano

Director

Dr. Mary Lynne Hedley,PhD

Director

Mr. Ralph Alvarez

Director

Ms. Katherine Baicker

Director

Mr. David A. Ricks

CEO/Chairman of the Board/Director/President

Dr. William G. Kaelin, Jr

Director

Mr. Donald A. Zakrowski

Chief Accounting Officer/Senior VP, Divisional

Mr. Marschall S. Runge

Director

Mr. Jamere Jackson

Director

Mr. Jacob S. Van Naarden

Executive VP/President, Subsidiary

Ms. Kimberly H. Johnson

Director

Ms. Karen Walker

Director

Ms. Anat Hakim

Executive VP/General Counsel/Secretary

Ms. Johna L. Norton

Executive VP, Divisional

Dr. Daniel M. Skovronsky, M.D.

Chief Scientific Officer/Executive VP/President, Divisional

Ms. Anne E. White

Executive VP/President, Divisional

Mr. Patrik Jonsson

Executive VP, Divisional/President, Divisional/President, Geographical

Mr. Ilya Yuffa

Executive VP/President, Subsidiary

Ms. Anat Ashkenazi

CFO/Executive VP

Mr. Edgardo Hernandez

Executive VP/President, Divisional

Mr. Diogo Rau

Chief Information Officer/Executive VP/Other Executive Officer

Mr. Alonzo Weems

Chief Compliance Officer/Executive VP, Divisional/Other Executive Officer

Mr. Eric Dozier

Executive VP, Divisional

Ownership

Institution Holdings

Lilly Endowment Inc

99,768,810 (10.500%)

Vanguard Group Inc

71,611,201 (7.537%)

BlackRock Inc

64,366,433 (6.774%)

PNC Financial Services Group Inc

51,789,291 (5.451%)

Capital Research and Management Company

39,925,234 (4.202%)

Fidelity Management & Research Company LLC

34,178,563 (3.597%)

State Street Corporation

33,787,327 (3.556%)

FMR Inc

32,845,420 (3.457%)

Capital Group

27,965,997 (2.943%)

Vanguard Investments Australia Ltd

27,285,971 (2.872%)

Funds Holdings

Vanguard US Total Market Shares ETF

26,857,819 (2.827%)

Vanguard Total Stock Market Index Fund

26,857,819 (2.827%)

Vanguard Institutional 500 Index Trust

19,706,689 (2.074%)

Vanguard PrimeCap Fund

12,848,118 (1.352%)

Fidelity 500 Index Fund

9,467,553 (0.996%)

SPDR® S&P 500 ETF Trust

9,359,505 (0.985%)

iShares Core S&P 500 ETF

8,296,124 (0.873%)

Vanguard Growth Index Fund

7,872,938 (0.829%)

American Funds Growth Fund of Amer

7,349,331 (0.773%)

Capital Group Growth Fnd of Amer Comp

7,349,331 (0.773%)

Details

Overview

Company Info

Key Ratios

Income

Balance Sheet

Cash Flow

Bubble

Make Smart Investment Choices